The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((9H-carbazol-9-yl)methyl)-10,11-dihydro-5H-dibenzo[b,f]azepine ID: ALA3810295
PubChem CID: 127043387
Max Phase: Preclinical
Molecular Formula: C27H22N2
Molecular Weight: 374.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc2c(c1)CCc1cc(Cn3c4ccccc4c4ccccc43)ccc1N2
Standard InChI: InChI=1S/C27H22N2/c1-4-10-24-20(7-1)14-15-21-17-19(13-16-25(21)28-24)18-29-26-11-5-2-8-22(26)23-9-3-6-12-27(23)29/h1-13,16-17,28H,14-15,18H2
Standard InChI Key: AHNXBJZDQOBFDK-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 34 0 0 0 0 0 0 0 0999 V2000
0.8722 -1.3706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1246 1.9313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6509 1.9313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2272 -0.7320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5854 0.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0183 1.1214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1241 0.0934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7970 -1.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3486 -1.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7943 0.7632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4672 -0.7164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5730 -1.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0215 -1.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3330 0.1557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2272 1.1993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5661 0.5103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6483 -0.5295 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0475 -1.1381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0189 -0.1462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3821 1.2597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7357 1.6340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7643 0.6421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4393 -0.7242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3149 -1.9132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3434 -2.9051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9930 -4.2978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6012 -4.7117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5727 -3.7198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9358 -2.3139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 1 1 0
1 4 1 0
10 2 1 0
5 3 1 0
2 3 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
7 16 1 0
16 17 1 0
17 19 1 0
18 25 1 0
24 17 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.49Molecular Weight (Monoisotopic): 374.1783AlogP: 6.69#Rotatable Bonds: 2Polar Surface Area: 16.96Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 0.70CX LogP: 7.04CX LogD: 7.04Aromatic Rings: 5Heavy Atoms: 29QED Weighted: 0.36Np Likeness Score: -0.55
References 1. Fukuda H, Ito S, Watari K, Mogi C, Arisawa M, Okajima F, Kurose H, Shuto S.. (2016) Identification of a Potent and Selective GPR4 Antagonist as a Drug Lead for the Treatment of Myocardial Infarction., 7 (5): [PMID:27190599 ] [10.1021/acsmedchemlett.6b00014 ]